Virtual Cardiology

Oct
28

Weighing the Evidence: A Pharmacy Approach to Stroke Prevention in Obese Patients with Non-Valvular Atrial Fibrillation

Atrial fibrillation (AF) is estimated to affect over 5 million people in the United States and is associated with a five-fold increase in the relative risk of stroke. Obesity is an independent risk factor for cardiovascular disease (CVD) and is also associated with increased risk of developing non-valvular AF (NVAF). Patients with comorbid NVAF and […]

Read More
By Ben Stoner |
DETAIL
Jun
29

Keeping the Beat: Screening and Management of High-Risk Patients with Non-Valvular Atrial Fibrillation

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, projected to affect 12 million Americans by 2030. However, a significant number of AF cases, particularly non-valvular atrial fibrillation (NVAF) remain undiagnosed, putting patients at risk for severe cardiovascular (CV) complications, including increased risk of stroke. It is imperative that clinicians identify the symptomatology of […]

Read More
By Ben Stoner |
DETAIL
Jun
27

Keeping the Beat: Screening and Management of High-Risk Patients with Non-Valvular Atrial Fibrillation

  Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, projected to affect 12 million Americans by 2030. However, a significant number of AF cases, particularly non-valvular atrial fibrillation (NVAF) remain undiagnosed, putting patients at risk for severe cardiovascular (CV) complications, including increased risk of stroke. This CME Outfitters OnDemand webcast will feature expert […]

Read More
DETAIL
Mar
18

Cardiology Education Hub

View the Cardiology Education Hub for resources and tools you can use in your practice and to educate your patients.

Read More
By Tom Meyers |
DETAIL